Codes / ICD10CM / F13.1

F13.1 Sedative, hypnotic or anxiolytic-related abuse

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Sedative, Hypnotic, or Anxiolytic-Related Abuse (ICD-10 Code: F13.1)

Summary

This condition involves the misuse of substances typically used for sedation, sleep induction, or anxiety relief, leading to significant impairment or distress. It is characterized by a pattern of use that deviates from medical guidance or societal norms, often resulting in negative consequences.

Causes

The condition arises from the non-medical use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. It may stem from recreational use, self-medication, or misuse of prescribed medications, often driven by the desire to achieve euphoria or alleviate stress.

Risk Factors

  • Contributing factors include a history of substance abuse, mental health disorders (e.g., anxiety or depression), chronic pain, and environments where drug use is normalized. Genetic predispositions and easy access to these medications can also increase risk.

Symptoms

  • Symptoms include using the substance in larger amounts or for longer than intended, persistent cravings, failure to fulfill major obligations due to use, and continued use despite social or interpersonal problems. Tolerance and withdrawal symptoms may also occur.

Diagnosis

Diagnosis is based on a clinical evaluation, including a detailed patient history and assessment of substance use patterns. Healthcare providers may use standardized criteria (e.g., DSM-5) to determine if the use meets criteria for abuse.

Treatment Options

  • Treatment often involves behavioral therapies, counseling, and support groups to address underlying issues and modify use patterns. In some cases, medication-assisted treatment or detoxification may be necessary to manage withdrawal or cravings.

Prognosis and Follow-Up

Prognosis varies depending on the severity of use and co-occurring conditions. Regular follow-up with a healthcare provider is essential to monitor progress, address relapse risks, and adjust treatment plans as needed.

Complications

  • Complications can include physical health issues (e.g., respiratory depression), mental health deterioration, social or occupational impairment, and increased risk of overdose or other substance-related disorders.

Lifestyle & Prevention

  • Prevention strategies include proper education on medication use, secure storage of prescribed drugs, and addressing stress or mental health concerns through non-pharmacological means. Avoiding self-medication and seeking help for substance use early can reduce risk.

When to Seek Professional Help

  • Seek help if substance use interferes with daily life, causes health problems, or leads to withdrawal symptoms. A healthcare provider can offer assessment, treatment, and resources for recovery.

Tips for Medical Coders

  • Document the specific substance(s) involved, the pattern of use (e.g., frequency, duration), and any associated impairments or consequences. Ensure the diagnosis aligns with clinical criteria for abuse, and note any contributing factors (e.g., mental health conditions) that support the code assignment.
Book a walkthrough

F13.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.